The Antibody Society is tracking over 200 biotechnology-derived protein-based COVID-19 interventions in preclinical and clinical development. Of the anti-SARS-CoV-2 monoclonal antibodies in development, over 30 have entered clinical study. An overview of these are included in the table below.For details regarding anti-SARS-CoV-2 biologics development, see: Strohl W.R., Ku Z., An Z. et al. Passive Immunotherapy … Continue reading COVID-19 Biologics Tracker